Digital Pathology & Imaging - software & AI news

Daily news on software, AI, and companies shaping digital pathology & imaging.

Showing 216 results
An ultrasound machine in a hospital examination room, showcasing medical diagnostics equipment.

Jul 18, 2026

GE and Catholic Health enter $500m alliance to expand diagnostics access

GE HealthCare and Catholic Health have forged a significant ten-year alliance worth approximately $500 million, aimed at enhancing access to precision diagnostics and advanced imaging technologies across Long Island.This collaboration, termed the Care Alliance, is set to introduce over 1,300 new pieces of medical equipment and technology throughout Catholic Health's network, including hospitals and outpatient facilities. The focus will be on modernizing equipment in critical clinical areas such
A smartphone on a table showing a health monitoring app in a cozy living room setting.

Jul 17, 2026

United States Digital Biomarkers Market Forecast to Reach US$

The Digital Biomarkers Market in the United States is projected to grow significantly, reaching approximately $39.28 billion by 2033, driven largely by advancements in neurological disease monitoring and AI analytics.The market, valued at $6.18 billion in 2025, is expected to expand at a compound annual growth rate (CAGR) of 22.7% between 2026 and 2033. This growth is fueled by the increasing adoption of digital biomarkers among healthcare providers, pharmaceutical companies, and research organi
AI-powered image screening device in a hospital examination room

Jul 17, 2026

Commission makes €63.2 million available to support AI innovation in health and online safety

The European Commission has announced the availability of €63.2 million to foster AI innovation in health and online safety, reflecting a strategic push towards enhancing digital services across Europe.This funding initiative includes a significant allocation of €9 million aimed at advancing AI-powered image screening technologies in medical facilities, which holds promise for improving the early detection and diagnosis of critical health issues like cancer and cardiovascular diseases. Additiona
A surgical robot arm in an operating room

Jul 16, 2026

Johnson & Johnson Builds Connected MedTech Platforms Around AI and Robotics

Johnson & Johnson is making significant strides in the MedTech sector by integrating AI and robotics into its healthcare platforms, as evidenced by its recent second-quarter financial performance.In the second quarter of 2026, Johnson & Johnson reported global sales of $25.3 billion, marking a 5.6% operational increase. Notably, the Innovative Medicine segment experienced a growth of 6.8%, driven by new product launches and robust demand. The company’s focus on technology is evident, particularl
A tissue sample on a microscope slide in a dimly lit lab

Jul 15, 2026

Global AI in Pathology Market Poised for Phenomenal Expansion at a CAGR of ~25% by 2034 | DelveInsight

The AI in pathology market is on track for remarkable growth, anticipated to reach a compound annual growth rate (CAGR) of approximately 25% by 2034. This surge is largely attributed to the increasing integration of digital pathology and the rising incidence of cancer, alongside a demand for more efficient and precise diagnostic processes.Factors propelling this expansion include significant investments in healthcare digitalization and the favorable regulatory environment that supports the adopt
A radiologist's hands adjusting MRI settings in a dimly lit imaging room with a breast scan on display.

Jul 14, 2026

Quibim launches CE and UKCA-marked QP-Breast

Quibim has introduced QP-Breast, an innovative AI tool now CE and UKCA-marked, designed to enhance breast cancer detection through magnetic resonance imaging (MRI) in Europe and the UK. This tool is significant as it is the first of its kind in these regions, automatically identifying suspicious lesions during breast MRI assessments.QP-Breast aims to support radiologists by improving the accuracy of lesion detection and generating concise, user-friendly reports that integrate with existing hospi
A minimalist illustration of a mosquito and a blood drop representing malaria diagnostics.

Jul 14, 2026

Noul's miLab MAL highlighted as leading AI malaria diagnostic in Harvard-led international study

Noul's miLab MAL has been recognized as a leading AI-driven diagnostic tool for malaria in a recent review published by a Harvard-led international research team.The study, featured in "npj Digital Medicine," highlights the effectiveness of Noul's miLab MAL in the context of the global malaria diagnostic landscape. Researchers employed a scoping review methodology, examining both traditional diagnostic methods like microscopy and PCR, alongside emerging AI technologies. This comprehensive approa
A microscope slide with a biological sample in a dimly lit lab setting.

Jul 13, 2026

Microscopy Software Market Size to Hit USD 5.24 Billion by 2035

The microscopy software market is projected to grow significantly, reaching USD 5.24 billion by 2035, driven by advancements in artificial intelligence (AI) and machine learning (ML).The global microscopy software market was valued at USD 1.75 billion in 2025 and is expected to expand at a compound annual growth rate (CAGR) of 11.60% from 2026 to 2035. North America is currently the leading region, accounting for 38% of the market share, while the Asia-Pacific region is anticipated to experience
Flat illustration of an MRI scan and brain silhouette

Jul 12, 2026

Viz.ai Partners With Cortechs.ai to Expand AI-Powered Neurodegenerative Disease Care

Viz.ai has announced a strategic partnership with Cortechs.ai to enhance care for neurodegenerative diseases, starting with multiple sclerosis (MS).The collaboration aims to integrate Cortechs.ai's NeuroQuant MS, a quantitative MRI analysis tool, into Viz.ai's Neuro Suite. This integration is set to streamline clinical workflows, allowing healthcare professionals to access critical MRI insights directly within the Viz platform. Such enhancements are expected to facilitate quicker identification
Flat illustration of a tissue sample with an AI brain overlay

Jul 11, 2026

AI in Cancer Diagnostics Market Anticipates Revenue of US$ 2,367.8 Million by 2034

The AI in cancer diagnostics market is poised for significant growth, projected to reach approximately $2.37 billion by 2034, up from $271.1 million in 2024, reflecting a compound annual growth rate (CAGR) of 24.2%.Artificial intelligence is increasingly integral to cancer diagnostics, enhancing early detection and accuracy. AI systems analyze extensive medical data, including imaging and pathology, to uncover patterns indicative of cancer. In medical imaging, AI aids radiologists by pinpointing
MRI machine in a hospital imaging room with a patient and radiologist

Jul 9, 2026

AI-Powered Imaging Diagnostics Market to Reach US$ 9.73 Billion

The AI-powered imaging diagnostics market is projected to grow significantly, reaching an estimated US$9.73 billion by 2033, with a compound annual growth rate (CAGR) of 22.3% from 2025 to 2033. This growth reflects a shift from pilot projects to operational frameworks in hospitals, where AI technologies are increasingly utilized for urgent scan triage and improved diagnostic workflows across various imaging modalities.Recent developments highlight the rapid advancement of AI in imaging diagnost
Flat illustration of a CT scan machine

Jul 9, 2026

AI-Powered Imaging Diagnostics Market Set to Reach USD 9.73

The AI-powered imaging diagnostics market is projected to grow significantly, reaching USD 9.73 billion by 2033, driven largely by advancements in artificial intelligence across various imaging modalities.This market, which was valued at USD 1.97 billion in 2025, is expected to expand at a compound annual growth rate (CAGR) of 22.3% from 2026 to 2033. Key factors contributing to this growth include the rising demand for enhanced diagnostic accuracy and efficiency, as well as the integration of A